We are live on
!
Find out more
VBIV
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
VBIV
Delisted
VBIV was delisted on the 7th of August, 2024.
130 hedge funds and large institutions have $83.3M invested in VBI Vaccines, Inc. New Common Stock (Canada) in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 38 increasing their positions, 44 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
311% more call options, than puts
Call options by funds: $407K | Put options by funds: $99K
8% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 13
1% less funds holding
Funds holding: 131 → 130 (-1)
14% less repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 44
56% less capital invested
Capital invested by funds: $191M → $83.3M (-$108M)
Holders
130
Holders Change
-1
Holders Change %
-0.76%
% of All Funds
2.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
38
Reduced
44
Closed
13
Calls
$407K
Puts
$99K
Net Calls
+$308K
Net Calls Change
-$312K
Top Buyers
| 1 |
Millennium Management
New York
|
+$1.37M |
| 2 |
Renaissance Technologies
New York
|
+$700K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$626K |
| 4 |
BlackRock
New York
|
+$552K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$444K |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$13.9M |
| 2 |
Rafferty Asset Management
New York
|
-$1.18M |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.17M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$771K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$609K |
